Efficacy and safety of Ombitasvir/paritaprevir/ritonavir and dasabuvir in non-cirrhotic Asian patients with genotype 1b chronic hepatitis C virus infection: ONYX-I post-treatment week 24 results

The requested reference [27a4b6eb86caf76b7ade8cb4c285e2b8bc95b924] no longer exists in our database. It has been replaced by the current reference: [dcf2ce8f3f15f7cd9530b97ee84391c89a102d0b]

Authors
Category Primary study
JournalJournal of Hepatology
Year 2017
This article has no abstract
Epistemonikos ID: c467e2b48f53c845f75ba8295aac3e6aaee208df
First added on: Feb 09, 2025